PMP Practice: Align scope with business objectives

This scenario tests the project manager's ability to navigate scope tradeoffs by anchoring decisions to documented project success criteria rather than simply mediating between stakeholders or defaulting to standard rules. The charter explicitly prioritizes market share capture and identifies the launch window as critical, while the regulatory guidance is still uncertain (may become mandatory, not is mandatory). The correct approach is to facilitate a decision-making session with the sponsor present, evaluate the requirement against the documented business objectives, and ensure the decision is made with full awareness of both business and technical risks. This respects the governance structure, uses the project charter as the decision framework, and ensures the sponsor exercises appropriate authority over a decision that fundamentally affects project success criteria. The key closing fact is that missing the launch window would likely halve market share, making schedule the dominant success factor unless regulatory exclusion is certain.

**Why not B:** This assumes regulatory compliance automatically overrides all other objectives without evaluating the specific context. The guidance may become mandatory, but is not yet, and the charter explicitly prioritizes market capture. This represents poor requirements prioritization that ignores documented success criteria and business strategy.

**Why not C:** While following change control is important, this response is overly procedural and abdicates the project manager's responsibility to facilitate strategic decision-making. The requirement has already emerged during validation workshops, and simply deferring to process without helping stakeholders understand tradeoffs against charter objectives fails the project manager's role in scope management. This also delays a time-sensitive decision.

**Why not D:** This compromise sounds collaborative but actually fails to address the core tradeoff. The manufacturing director's concern is timeline impact on competitive positioning, not the existence of biosensor capability itself. A compromise that still delays launch does not resolve the fundamental conflict. More importantly, this approach makes a strategic decision (splitting the feature) without involving the sponsor or evaluating against the charter's explicit success criteria, which is outside the project manager's authority.